Study of a Primary Care Hypoglycemia Prevention Program
- Conditions
- Diabetes MellitusHypoglycemia
- Interventions
- Other: Clinic Staff GroupOther: Primary Care Physician GroupOther: Patient Group (Hypoglycemia Prevention Program)
- Registration Number
- NCT06353217
- Lead Sponsor
- Johns Hopkins University
- Brief Summary
This is a single site, pre-post pilot study. The objective is to evaluate the acceptability and feasibility of a primary care hypoglycemia prevention program for patients taking hypoglycemia-causing medications. The study will also evaluate relevant process outcomes and clinical outcomes for refining the intervention and planning for a larger efficacy trial.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 35
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Clinic Staff Involvement Clinic Staff Group - Primary Care Physician (PCP) Involvement Primary Care Physician Group PCPs will be given access to the Hypoglycemia Prevention toolkit Patient Involvement Patient Group (Hypoglycemia Prevention Program) Patients who participate in the study will undergo one Baseline Clinic Visit (baseline usual care), and one Intervention clinic visit.
- Primary Outcome Measures
Name Time Method Overall acceptability to clinic staff Immediately after the intervention Mean score for overall acceptability on clinic staff intervention evaluation survey (developed for this study, range 1-completely unacceptable, to 5-completely acceptable)
Overall acceptability to primary care providers Immediately after the intervention Mean score for overall acceptability on primary care provider intervention evaluation survey (developed for this study, range 1-completely unacceptable, to 5-completely acceptable)
Overall acceptability to patients Immediately after the intervention Mean score for overall acceptability on patient intervention evaluation survey (developed for this study, range 1-completely unacceptable, to 5-completely acceptable)
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Johns Hopkins University School of Medicine
🇺🇸Baltimore, Maryland, United States